Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios.
Mathematical models provide valuable insights into the public health and economic impact of cervical cancer vaccination programmes. An in-depth economic analysis should explore the effects of different vaccine-related factors and vaccination scenarios (independent of screening practices) on health benefits and costs. In this analysis, a Markov cohort model was used to explore the impact of vaccine characteristics (e.g. cross-type protection and waning of immunity) and different vaccination scenarios (e.g. age at vaccination and multiple cohort strategies) on the cost-effectiveness results of cervical cancer vaccination programmes. The analysis was applied across different regions in the world (Chile, Finland, Ireland, Poland and Taiwan) to describe the influence of location-specific conditions. The results indicate that in all the different settings cervical cancer vaccination becomes more cost-effective with broader and sustained vaccine protection, with vaccination at younger ages, and with the inclusion of several cohorts. When other factors were varied, the cost-effectiveness of vaccination was most negatively impacted by increasing the discount rate applied to costs and health effects.
Suárez
Eugenio
E
Gynecological Oncology Department, San Borja Arriarán Clinical Hospital, School of Medicine, University of Chile, Santiago, Chile.
Smith
Jennifer S
JS
Bosch
F Xavier
FX
Nieminen
Pekka
P
Chen
Chien-Jen
CJ
Torvinen
Saku
S
Demarteau
Nadia
N
Standaert
Baudouin
B
D015331:Cohort Studies; D003365:Costs and Cost Analysis; D005260:Female; D006801:Humans; D017059:Models, Econometric; D009313:National Health Programs / Q000191:economics*; D002583:Uterine Cervical Neoplasms / Q000191:economics* / Q000517:prevention & control*